George Matcham
Director/Board Member bij INSTIL BIO, INC.
Vermogen: 19 586 $ op 31-03-2024
Profiel
George Matcham currently works at Instil Bio, Inc., as Independent Director from 2018.
Dr. Matcham also formerly worked at Chimeric Therapeutics Ltd.
(Australia), as Non-Executive Director from 2021 to 2023, Celgene Corp., as SVP-CAR T CMC & Technology Development from 2017 to 2018, and Celgene Cellular Therapeutics, as Chief Operating Officer.
Dr. Matcham received his graduate degree from the University of Cambridge and undergraduate degree and doctorate degree from the University of Cardiff.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-09-2023 | 1 000 800 ( 0.12% ) | 19 586 $ | 31-03-2024 | |
INSTIL BIO, INC.
-.--% | 14-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van George Matcham
| Bedrijven | Functie | Begin |
|---|---|---|
| INSTIL BIO, INC. | Director/Board Member | 01-09-2018 |
Eerdere bekende functies van George Matcham
| Bedrijven | Functie | Einde |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 03-08-2023 |
| CELGENE | Corporate Officer/Principal | 01-06-2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Chief Operating Officer | - |
Opleiding van George Matcham
| University of Cambridge | Graduate Degree |
| University of Cardiff | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
